The latest closing stock price for Spyre Therapeutics as of March 27, 2025 is 17.69.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-928 today, roughly -1 times their original investment - a -25.30% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 40.84, which is 130.9% above the current share price.
The Spyre Therapeutics 52-week low stock price is 16.71, which is 5.5% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 28.11.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-928 today, roughly -1 times their original investment - a -25.30% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 40.84, which is 130.9% above the current share price.
The Spyre Therapeutics 52-week low stock price is 16.71, which is 5.5% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 28.11.